蘆薈 Aloe Vera
B 1 C 1 D 1
適應症與證據等級
法規與權威立場 (L4)
L4a · US FDA
立場：against
The stimulant laxative ingredients aloe (including aloe extract and aloe flower extract) and cascara sagrada (including casanthranol, cascara fluidextract aromatic, cascara sagrada bark, cascara sagrada extract, and cascara sagrada fluidextract) in OTC drug products are not generally recognized as safe and effective or are misbranded.
來源 ↗ L4b · EU EFSA
立場：against
L4c · UK NHS
立場：not_addressed
The use of Aloe vera in treatment of IBS should be discouraged, as aloe vera has been shown to be of no benefit in IBS compared to placebo.
來源 ↗ L4d · TW TFDA / 衛福部
立場：cautious
費拉蘆薈(Aloe vera)及好望角蘆薈(A. ferox)品種的葉子，須確實完全去皮後，才能加工使用，且蘆薈素(aloin)的含量不可以超過10 ppm。使用蘆薈葉作為原料之食品必須標示「孕婦忌食」警語字樣；產品檢具經檢驗機構檢驗所含「蘆薈素」含量低於1 ppm之分析證明者，得免標前述之警語。
來源 ↗ L4e · WHO
立場：cautious
Aloe whole leaf extract is possibly carcinogenic to humans (Group 2B). [IARC Monographs Vol. 108, 2016 — sufficient evidence of carcinogenicity in experimental animals, inadequate evidence in humans]
來源 ↗ 市場與行銷 (L10)
L10a · TW Market Channels
Herb U Yogurt-aloe 蘆薈優格 TWD 55
L10b · TW Legal Identity (TFDA)
蘆薈要當作食品原料，必須是費拉蘆薈（Aloe vera）及好望角蘆薈（A. ferox）品種的葉子，且須確實完全去皮後，才能加工使用；使用蘆薈葉作為原料之食品，蘆薈素（aloin）的含量不可以超過 10 ppm。
L10c · TW Community (PTT/Dcard/Mobile01)
地瓜 蘆薈綠茶 白木耳